News
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...
I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...
The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...
Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.
An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.
Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results